Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Besivance vs. VIGAMOX for cataract surgery prophylaxis
NCT01296542Phase 4Completed
- Sponsor
- Bucci Laser Vision Institute
- Start
- May 2011
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of besifloxacin, Moxisurge in bacterial conjunctivitis (BC), endophthalmitis, sponsored by Bucci Laser Vision Institute. Started May 2011; status: completed.
02
Drugs
besifloxacinMoxisurge
03
Conditions
bacterial conjunctivitis (BC)endophthalmitis
Beyond the preview
Go deeper on NCT01296542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01296542.